Challenges in the diagnosis of Parkinson's disease
Parkinson's disease is the second most common neurodegenerative disease and its
prevalence has been projected to double over the next 30 years. An accurate diagnosis of …
prevalence has been projected to double over the next 30 years. An accurate diagnosis of …
Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis
Objective: To evaluate the diagnostic accuracy of clinical diagnosis of Parkinson disease
(PD) reported in the last 25 years by a systematic review and meta-analysis. Methods: We …
(PD) reported in the last 25 years by a systematic review and meta-analysis. Methods: We …
Detection of neuron-derived pathological α-synuclein in blood
To date, no reliable clinically applicable biomarker has been established for Parkinson's
disease. Our results indicate that a long anticipated blood test for Parkinson's disease may …
disease. Our results indicate that a long anticipated blood test for Parkinson's disease may …
Current and projected future economic burden of Parkinson's disease in the US
W Yang, JL Hamilton, C Kopil, JC Beck… - npj Parkinson's …, 2020 - nature.com
Parkinson's disease (PD) is one of the world's fastest growing neurological disorders. Much
is unknown about PD-associated economic burdens in the United States (US) and other …
is unknown about PD-associated economic burdens in the United States (US) and other …
[HTML][HTML] Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety
The use of data generated passively by personal electronic devices, such as smartphones,
to measure human function in health and disease has generated significant research …
to measure human function in health and disease has generated significant research …
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes
The elevated risk of Parkinson's disease in patients with diabetes might be mitigated
depending on the type of drugs prescribed to treat diabetes. Population data for risk of …
depending on the type of drugs prescribed to treat diabetes. Population data for risk of …
Dementia with Lewy bodies: an update and outlook
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder
producing progressive cognitive decline that interferes with normal life and daily activities …
producing progressive cognitive decline that interferes with normal life and daily activities …
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy
S Dutta, S Hornung, A Kruayatidee, KN Maina… - Acta …, 2021 - Springer
The diagnosis of Parkinson's disease (PD) and atypical parkinsonian syndromes is difficult
due to the lack of reliable, easily accessible biomarkers. Multiple system atrophy (MSA) is a …
due to the lack of reliable, easily accessible biomarkers. Multiple system atrophy (MSA) is a …
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
M Chin-Chan, J Navarro-Yepes… - Frontiers in cellular …, 2015 - frontiersin.org
Neurodegenerative diseases including Alzheimer (AD) and Parkinson (PD) have attracted
attention in last decades due to their high incidence worldwide. The etiology of these …
attention in last decades due to their high incidence worldwide. The etiology of these …
Epidemiology of Parkinson's disease
OB Tysnes, A Storstein - Journal of neural transmission, 2017 - Springer
Parkinson's disease (PD) affects 1–2 per 1000 of the population at any time. PD prevalence
is increasing with age and PD affects 1% of the population above 60 years. The main …
is increasing with age and PD affects 1% of the population above 60 years. The main …